The number of interventional trials is still rising, with now 30 trials that will include more than 1,000 patients each. The most tested drugs remain Hydoxychloroquine and antivirals.
We also provide insights on the modes of action of the different drugs tested, thanks to a James M. Sanders et al.
COVIDNews CEPTON-INATO #3
CEPTON Strategies news
Here are all the reports and analysis we published along with the press articles about us
CEPTON is the author of many publications in the field of healthcare and pharmaceuticals and our partners are often interviewed by the specialized press.
titre
Posted on 26.10.2022 by Marc-Olivier Bévierre
Vintura and Cepton join forces!
Posted on 03.05.2022 by Marc-Olivier Bévierre
Connected Medical Devices: Thriving opportunities for better healthcare (Part II)
Posted on 23.03.2021 by Marc-Olivier Bévierre
Posted on 23.03.2021 by Marc-Olivier Bévierre
Connected Medical Devices: Thriving opportunities for better healthcare (Part I)
Posted on 25.02.2021 by Marc-Olivier Bévierre
Connected medical devices embedded in AI: the wave is coming
Posted on 14.01.2021 by Marc-Olivier Bévierre
Contact us
You have a question, an issue you would like to share with us
Feel free to contact us to arrange a meeting or a teleconference, using the form below.
You would like to apply for a job with us
We are always happy to welcome new profiles in our teams, please fill the following form to apply for a job in CEPTON.